1503785-54-3Relevant academic research and scientific papers
CF3-substituted mollugin 2-(4-morpholinyl)-ethyl ester as a potential anti-inflammatory agent with improved aqueous solubility and metabolic stability
Hong, Ki Bum,Kim, Darong,Kim, Bo-Kyung,Woo, Seo Yeon,Lee, Ji Hoon,Han, Seung-Hee,Bae, Gyu-Un,Kang, Soosung
, (2018)
Although mollugin, the main ingredient of the oriental medicinal herb Rubia cordifolia, has considerable anti-inflammatory effects, it has poor aqueous solubility as well as poor metabolic and plasma stability. To overcome these shortfalls, various mollug
MOLLUGIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING THE SAME
-
, (2020/09/12)
The present invention relates to a pharmaceutical composition for treating inflammatory bowel diseases, comprising mollugin or a mollugin derivative applicable as a therapeutic agent for inflammatory bowel diseases, as an effective component. More specifi
MOLLUGIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING THE SAME
-
, (2019/12/25)
The present invention relates to a pharmaceutical composition for treating inflammatory bowel disease, comprising mollugin or a mollugin derivative which can be beneficially used as a therapeutic agent for inflammatory bowel disease. More specifically, th
